Latest Research

Paragon Care (PGC) - Strong Vital Signs

Paragon Care Logo

A strong 2H17 meant PGC met or exceeded guidance and expectations for the full year. Vital signs are good; revenue growth, margin expansion, and strong operating cash flow are a healthy combination. Evidence suggests the strategy to consolidate a fragmented industry is well considered. Businesses are being successfully integrated onto the growing platform, synergies extracted, and cross-selling opportunities targeted. We have upped our valuation to $1.12 (prior $1.05) on the back of a solid FY17 and believe there is both organic and acquisitive growth upside. Buy maintained.

To access our review of Paragon Care please log in under the Client Area Log In at the bottom of this page.

Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.

If you would like to access our research please contact us to create an account.

Perth:
This email address is being protected from spambots. You need JavaScript enabled to view it.
+61 8 9224 6888

Hong Kong:
This email address is being protected from spambots. You need JavaScript enabled to view it.
+852 3557 4888

 



Google+